Overcoming docetaxel resistance in prostate cancer: a perspective review.

Authors:
Hwang C.

Journal:
Ther Adv Med Oncol

Publication Year: 2012

DOI:
10.1177/1758834012449685

PMCID:
PMC3481557

PMID:
23118808

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Med Oncol

Abbreviation: Ther Adv Med Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-an…
Petrelli F; Antista M; Marra F and 8 more (2024) - Transparency Score: 3/6
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluati…
Sepe P; Procopio G; Pircher CC and 16 more (2024) - Transparency Score: 4/6
A prospective phase II single-arm study and predictive factor analysis of irinotecan as third-line …
Yu N; Huang S; Zhang Z and 9 more (2024) - Transparency Score: 4/6
Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer.
Bai Q; Shi X; Zhou X and 3 more (2024) - Transparency Score: 3/6
Chronological improvement of survival in patients with advanced gastric cancer over 15 years.
Ogata T; Narita Y; Oze I and 14 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest statement: The author declares no conflict of interest."

Evidence found in paper:

"Funding: Dr Hwang would like to thank Henry Ford Hospital and the Vattikuti Urology Institute for their financial support."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025